Test Bank for Project Management in Practice 7th Edition by Jack R. Meredith & Scott M. Shafer – Complete Questions & Answers Study Guide

lOMoARcPSD|327 b 44 6 9
l1OM oARcPSD|327 b 441

b 69




Test Bank For:
b b




Pharmacotherapeutics For Advanced Practice A
b b b b




Practical Approach 5th North American Edition
b b b b b b




Complete Guide Exam Prep Pdf
b b b b b

, lOMoARcPSD|327 b 441
b69




TABLE OF CONTENT
b b




o Chapter 1: Issues for the Practitioner in Drug Therapy
b b b b b b b b




o Chapter 2: Pharmacokinetic Basis of Therapeutics and Pharmacodynamic Principles
b b b b b b b b




o Chapter 3: Impact of Drug Interactions and Adverse Events on Therapeutics
b b b b b b b b b b




o Chapter 4: Principles of Pharmacotherapy in Pediatrics, Pregnancy and Lactation
b b b b b b b b b




o Chapter 5: Pharmacotherapy Principles in Older Adults
b b b b b b




o Chapter 6: Principles of Antimicrobial Therapy
b b b b b




o Chapter 7: Pharmacogenomics
b b




o Chapter 8: The Economics of Pharmacotherapeutics
b b b b b




o Chapter 9: Principles of Pharmacology in Pain Management
b b b b b b b




o Chapter 10: Pain Management in Opioid Use Disorder (OUD) Patients
b b b b b b b b b




o Chapter 11: Cannabis and Pain Management
b b b b b




o Chapter 12: Dermatitisb b




o Chapter 13: Bacterial, Fungal, and Viral Infections of the Skin
b b b b b b b b b




o Chapter 14: Psoriasis b b




o Chapter 15: Acne Vulgaris and Rosacea
b b b b b




o Chapter 16: Ophthalmic Disorders
b b b




o Chapter 17: Otitis Media and Otitis Externa
b b b b b b




o Chapter 18: Hypertension
b b




o Chapter 19: Hyperlipidemia
b b




o Chapter 20: Chronic Stable Angina and Myocardial Infarction
b b b b b b b




o Chapter 21: Heart Failure
b b b




o Chapter 22: Arrhythmias
b b




o Chapter 23: Respiratory Infections
b b b




o Chapter 24: Asthma and Chronic Obstructive Pulmonary Disease
b b b b b b b




o Chapter 25: Gastric, Functional and Inflammatory Bowel Disorders
b b b b b b b b




o Chapter 26: Gastroesophageal Reflux Disease and Peptic Ulcer Disease
b b b b b b b b




o Chapter 27: Liver Diseases
b b b




o Chapter 28: Urinary Tract Infection
b b b b




o Chapter 29: Prostatic Disorders and Erectile Dysfunction
b b b b b b b




o Chapter 30: Overactive Bladder
b b b




o Chapter 31: Sexually Transmitted Infections
b b b b




o Chapter 32: Osteoarthritis and Gout
b b b b




o Chapter 33: Osteoporosis
b b




o Chapter 34: Rheumatoid Arthritis
b b b




o Chapter 35: Headaches b b




o Chapter 36: Seizure Disorders
b b b




o Chapter 37: Alzheimer’s Disease
b b b




o Chapter 38: Parkinson Disease
b b b




o Chapter 39: Major Depressive Disorder and Bipolar Disorders
b b b b b b b




o Chapter 40: Anxiety Disorders
b b b




o Chapter 41: Sleep Disorders
b b b




o Chapter 42: Attention Deficit Hyperactivity Disorder
b b b b b




o Chapter 43: Substance Use Disorders
b b b b




o Chapter 44: Diabetes Mellitus
b b b




o Chapter 45: Thyroid and Parathyroid Disorders
b b b b b




o Chapter 46: Allergies and Allergic Reactions o
b b b b b b




bChapter 47: Human Immunodeficiency Virus o
b b b b b




bChapter 48: Organ Transplantation
b b b




o Chapter 49: Pharmacotherapy for Select Thromboembolic Disorders
b b b b b b




o Chapter 50: Anemias b b




o Chapter 51: Immunizations
b b




o Chapter 52: Smoking Cessation
b b b




o Chapter 53: Weight Loss b b b




o Chapter 54: Contraception
b b

, lOMoARcPSD|327 b 441
b69


o Chapter 55: Menopause b b




o Chapter 56: Vaginitis b b




Chapter 1 Issues for the Practitioner in Drug Therapy
b b b b b b b b




MULTIPLE CHOICEb




1. Nurse practitioner prescriptive authority is regulated by:
b b b b b b




A. The National Council of State Boards of Nursing
b b b b b b b




B. The U.S. Drug Enforcement Administration
b b b b




C. The State Board of Nursing for each state
b b b b b b b




D. The State Board of Pharmacy b b b b




ANS: C b PTS: 1

2. Physician Assistant (PA) prescriptive authority is regulated by:
b b b b b b b




A. The National Council of State Boards of Nursing
b b b b b b b




B. The U.S. Drug Enforcement Administration
b b b b




C. The State Board of Nursing b b b b




D. The State Board of Medical Examiners
b b b b b




ANS: D b PTS: 1

3. Clinical judgment in prescribing includes:
b b b b




A. Factoring in the cost to the patient of the medication prescribed
b b b b b b b b b b




B. Always prescribing the newest medication available for the disease process
b b b b b b b b b




C. Handing out drug samples to poor patients b b b b b b




D. Prescribing all generic medications to cut costs b b b b b b




ANS: A b PTS: 1

4. Criteria for choosing an effective drug for a disorder include:
b b b b b b b b b




A. Asking the patient what drug they think would work best for them
b b b b b b b b b b b




B. Consulting nationallyrecognized guidelines for disease management b b b b b b




C. Prescribing medications that are available as samples before writing a prescription
b b b b b b b b b b




D. Following U.S. Drug Enforcement Administration (DEA) guidelines for
b b b b b b b




prescribing
b




ANS: B b PTS: 1

5. Nurse practitioner practice may thrive under health-care reform due to:
b b b b b b b b b




A. The demonstrated ability of nurse practitioners to control costs and improve patient
b b b b b b b b b b b




outcomes
b




B. The fact that nurse practitioners willbe abletopractice independently
b b b b b b b b b b




C. The fact that nurse practitioners will have full reimbursement under health-care
b b b b b b b b b b




reform
b




D. The ability to shift accountability for Medicaid to the state level
b b b b b b b b b b




ANS: A b PTS: 1

, lOMoARcPSD|327 b 441
b69




Chapter 2.Pharmacokinetic Basis of Therapeutics and Pharmacodynamic
b b b b b b




MULTIPLE CHOICE b




1. A patient’s nutritional intake and lab workreflects hypoalbuminemia. This is critical to
b b b b b b b b b b b b




prescribingbecause:
b




A. Distribution of drugs to target tissue may be affected b b b b b b b b




B. The solubility of the drug will not match the site of absorption
b b b b b b b b b b b




C. There will beless freedrug available togenerate aneffect
b b b b b b b b b b




D. Drugs bound to albumin are readily excreted by the kidney
b b b b b b b b b




ANS: A b PTS: 1

2. Drugs that have a significant first-pass effect:
b b b b b b




A. Must be given by the enteral (oral) route only
b b b b b b b b




B. Bypass the hepatic circulation b b b




C. Are rapidly metabolized by the liver and may have little if any desired action
b b b b b b b b b b b b b




D. Are converted by the liver to more active and fat-soluble forms
b b b b b b b b b b




ANS: C b PTS: 1

3. The route of excretion of a volatile drug will likelybe:
b b b b b b b b b b




A. The kidneys b




B. The lungs b




C. The bile and feces b b b




D. The skin b




ANS: B b PTS: 1

4. Medroxyprogesterone (Depo Provera) is prescribed IM to create a storage reservoir of the b b b b b b b b b b b b




drug.Storagereservoirs:
b b b




A. Assure that the drug will reach its intended target tissue b b b b b b b b b




B. Are the reason for giving loading doses
b b b b b b




C. Increase the length of time a drug is available and active b b b b b b b b b b




D. Are most common in collagen tissues
b b b b b




ANS: C b PTS: 1

5. The NP chooses to give cephalexin every 8 hours based on knowledge of the drug’s:
b b b b b b b b b b b b b b




A. Propensity to go to the target receptor b b b b b b




B. Biologicalhalf-life b




C. Pharmacodynamics
D. Safetyand side effects b b b




ANS: B b PTS: 1

6. Azithromycin dosing requires the first day’s dose be twice those of the other 4 days ofthe
b b b b b b b b b b b b b b b b




prescription. This is considered a loading dose. A loading dose:
b b b b b b b b b b




A. Rapidly achieves drug levels in the therapeutic range b b b b b b b




B. Requires four to five half-lives to attain b b b b b b




C. Is influenced by renal function
b b b b